Paysign, Inc. (NASDAQ:PAYS) CEO Mark Newcomer Sells 25,000 Shares of Stock

Paysign, Inc. (NASDAQ:PAYS) CEO Mark Newcomer sold 25,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $3.27, for a total value of $81,750.00. Following the completion of the transaction, the chief executive officer now directly owns 9,236,886 shares of the company’s stock, valued at $30,204,617.22. This represents a 0.27 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Mark Newcomer also recently made the following trade(s):

• On Monday, November 18th, Mark Newcomer sold 40,000 shares of Paysign stock. The shares were sold at an average price of $3.24, for a total transaction of $129,600.00.
• On Wednesday, October 23rd, Mark Newcomer sold 36,000 shares of Paysign stock. The shares were sold at an average price of $3.66, for a total value of $131,760.00.
• On Monday, October 21st, Mark Newcomer sold 22,000 shares of Paysign stock. The shares were sold at an average price of $3.75, for a total value of $82,500.00.
• On Monday, September 23rd, Mark Newcomer sold 50,000 shares of Paysign stock. The stock was sold at an average price of $4.25, for a total transaction of $212,500.00.
• On Thursday, September 19th, Mark Newcomer sold 1,500 shares of Paysign stock. The shares were sold at an average price of $4.50, for a total transaction of $6,750.00.
• On Friday, September 13th, Mark Newcomer sold 1,500 shares of Paysign stock. The stock was sold at an average price of $4.50, for a total transaction of $6,750.00.

Paysign Stock Performance

Shares of PAYS opened at $3.39 on Thursday. The firm has a market cap of $181.53 million, a P/E ratio of 22.60 and a beta of 0.95. Paysign, Inc. has a fifty-two week low of $2.22 and a fifty-two week high of $5.59. The business has a 50-day moving average of $3.85 and a 200 day moving average of $4.29.

Paysign (NASDAQ:PAYS) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.02. The company had revenue of $15.26 million for the quarter, compared to analyst estimates of $14.96 million. Paysign had a net margin of 14.28% and a return on equity of 30.64%. During the same quarter in the previous year, the firm posted $0.02 earnings per share. As a group, research analysts predict that Paysign, Inc. will post 0.21 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Paysign

Several institutional investors have recently made changes to their positions in PAYS. SG Americas Securities LLC purchased a new position in shares of Paysign in the third quarter valued at $43,000. Algert Global LLC purchased a new position in Paysign during the second quarter valued at approximately $46,000. The Manufacturers Life Insurance Company bought a new stake in Paysign during the 2nd quarter worth approximately $66,000. American Century Companies Inc. bought a new stake in Paysign during the 2nd quarter worth approximately $92,000. Finally, Bard Associates Inc. bought a new position in Paysign in the 3rd quarter valued at $103,000. Hedge funds and other institutional investors own 25.89% of the company’s stock.

Analysts Set New Price Targets

Separately, Barrington Research reissued an “outperform” rating and issued a $7.00 price target on shares of Paysign in a research report on Monday, November 4th.

About Paysign

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.